World's Best Scientists 2026 revealed!
Sarcoma
H-index 10

Sarcoma

1357-714X

Published by: Hindawi

https://www.hindawi.com/journals/sarcoma/

Ranking & Metrics

Discipline name Position Best Scientists Publications D-Index
Medicine 2383 31 28 10

Additional Metrics

Number of Best Scientists*: 39
Documents by Best Scientists*: 33
Top 100 Ranked Scientists*: 0
SCIMAGO H-index: 55
SCIMAGO SJR: 0.666
Impact Factor: N/A

Overview

Top Research Topics at Sarcoma?

The main points discussed in the journal deals with Surgery, Sarcoma, Pathology, Internal medicine and Chemotherapy. As a part of the journal, discussions in Surgery involve topics like Radiation therapy, Soft tissue sarcoma, Soft tissue, Amputation and Resection. Topics in Sarcoma explored in Sarcoma were investigated in conjunction with research in Cancer and Radiology, Leiomyosarcoma.

The Pathology works featured in it incorporate elements from Cancer research and Metastasis. It focuses on Cancer research but the discussions also offer insight into other areas such as Cell culture and Bioinformatics. The in-depth study on Bioinformatics also explores topics in the intersecting field of Gene.

The research on Internal medicine tackled can also make contributions to studies in the areas of Gastroenterology and Oncology. The Chemotherapy research dealing mostly with Ifosfamide is the focus of the journal.

  • Surgery (37.85%)
  • Sarcoma (30.51%)
  • Pathology (27.97%)

What are the most cited papers published in the journal?

  • Guidelines for the Management of Soft Tissue Sarcomas (309 citations)
  • A meta-analysis of osteosarcoma outcomes in the modern medical era. (267 citations)
  • The Molecular Pathogenesis of Osteosarcoma: A Review (242 citations)

Research areas of the most cited articles at Sarcoma:

The journal publications tackle a plethora of topics, such as Pathology, Surgery, Sarcoma, Chemotherapy and Internal medicine. The studies on Pathology discussed at the published articles can also contribute to research in the domains of Radiology, Cancer research and Metastasis. While work presented in the published papers provide substantial information on Sarcoma, it also covers topics in Tibia and Soft tissue.

What topics the last edition of the journal is best known for?

  • Cancer
  • Internal medicine
  • Surgery

The previous edition focused in particular on these issues:

The journal investigates studies in Sarcoma, Radiation therapy, Disease, Internal medicine and MEDLINE. The studies in Sarcoma featured incorporate elements of Individualized treatment and Leiomyosarcoma. The concepts on Radiation therapy presented in it can also apply to other research fields, including Cancer, Chemotherapy, Database, Perioperative and Proportional hazards model.

The overlapping concepts between Soft tissue and Epigenetics, Chromatin, Carcinogenesis, Bioinformatics and Clinical trial are the key highlights of Disease study. The work tackled in the journal goes beyond the discipline of Internal medicine as it also encompasses Oncology. The Soft tissue sarcoma research presented in it explores the relationship between Female sex and the closely related topic of Surgery.

The most cited articles from the last journal are:

  • Predictors of Recurrence and Patterns of Initial Failure in Localized Ewing Sarcoma: A Contemporary 20-Year Experience. (1 citations)
  • Postradiation Fractures after Combined Modality Treatment in Extremity Soft Tissue Sarcomas. (1 citations)
  • Reconstructive Challenges of Distal Tibia Bone Tumors: Extracorporeally Irradiated Autograft Combined with a Nonvascularized Autograft Fibula for Superior Reconstruction and Functional Outcomes When Compared to Ipsilateral Pedicled Fibula Transfer Alone (1 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

The top authors publishing in Sarcoma (based on the number of publications) are:

  • Robert J. Grimer (32 papers) absent at the last edition,
  • Simon R. Carter (18 papers) absent at the last edition,
  • Roger M. Tillman (16 papers) absent at the last edition,
  • Ian Judson (15 papers) absent at the last edition,
  • Jay S. Wunder (13 papers) published 1 paper at the last edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Only papers with recognized affiliations are considered

The top affiliations publishing in Sarcoma (based on the number of publications) are:

  • Memorial Sloan Kettering Cancer Center (35 papers) published 2 papers at the last edition the same number as at the previous edition,
  • Royal Orthopaedic Hospital (34 papers) absent at the last edition,
  • University of Texas MD Anderson Cancer Center (31 papers) published 1 paper at the last edition, 5 less than at the previous edition,
  • The Royal Marsden NHS Foundation Trust (25 papers) absent at the last edition,
  • Harvard University (23 papers) absent at the last edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 10.53% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 29.41% were posted by at least one author from the top 10 institutions publishing in the journal. Another 23.53% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 17.65% of all publications and 29.41% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

  • Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
  • Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
  • Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
  • Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
  • Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Career Opportunities and Educational Pathways in Sarcoma Research

As one can note from the research topics discussed and the importance of varied fields within sarcoma studies such as Pathology, Surgery, and Chemotherapy, dedication and specialization are pivotal in the field. For those readers who may be inspired to make a contribution to the field, let's explore the potential career paths and education requirements one needs to undertake to become a prominent figure in this research area. While there are various paths to enter the sarcoma research field, one common route is through a healthcare career, such as becoming a nurse practitioner with a specialty in oncology. In this instance, individuals would first need to complete a registered nursing program and then satisfy the requirements of a nurse practitioner program related to oncology. Many universities in regions like Iowa provide such programs that equip students with advanced skills and experiences to contribute effectively to research areas like sarcoma. Those interested to pursue this path can refer to the nurse practitioner program requirements in Iowa to understand the detailed steps involved in starting this promising and impactful healthcare career. Remember, whether you are a budding radiologist, an aspiring genetic scientist, or a motivated nurse practitioner - every professional can contribute to sarcoma research in unique and significant ways. Hence, the journey often starts by acquiring the necessary education and training. Stay updated with the latest research, understand the implications of recent studies, try to participate in forums, and continually strive for advancements in providing effective solutions for sarcoma patients.

Top Publications

  • Diagnostic Differences in Expert Second-Opinion Consultation Cases at a Tertiary Sarcoma Center

    (2020)
    35 Citations
  • Diagnostic Value of TLE1 in Synovial Sarcoma: A Systematic Review and Meta-Analysis.

    Marc El Beaino;Marc El Beaino;Daniel C. Jupiter;Tarek Assi;Elie Rassy

    (2020)
    30 Citations
  • Clinical Presentation, Natural History, and Therapeutic Approach in Patients with Solitary Fibrous Tumor: A Retrospective Analysis.

    P. Schöffski;I. Timmermans;D. Hompes;M. Stas

    (2020)
    30 Citations
  • Results of a Randomized, Double-Blinded, Placebo-Controlled, Phase 2.5 Study of Saracatinib (AZD0530), in Patients with Recurrent Osteosarcoma Localized to the Lung.

    Kristin Baird;John Glod;Seth M. Steinberg;Denise Reinke

    (2020)
    23 Citations
  • Epidemiology of Soft Tissue Sarcoma and Bone Sarcoma inItaly: Analysis of Data from 15 Population-Based Cancer Registries

    Sabrina Fabiano;Paolo Contiero;Giulio Barigelletti;Anna D’Agostino

    (2020)
    20 Citations
  • PET/CT Imaging as a Diagnostic Tool in Distinguishing Well-Differentiated versus Dedifferentiated Liposarcoma.

    Amanda Parkes;Amanda Parkes;Elizabeth Urquiola;Priya Bhosale;Heather Lin

    (2020)
    20 Citations
  • Postradiation Fractures after Combined Modality Treatment in Extremity Soft Tissue Sarcomas.

    Meredith K. Bartelstein;Divya Yerramilli;Alexander B. Christ;Shachar Kenan

    (2021)
    14 Citations
  • Survey of Paediatric Oncologists and Pathologists regarding Their Views and Experiences with Variant Translocations in Ewing and Ewing-Like Sarcoma: A Report of the Children's Oncology Group.

    Michael D. Kinnaman;Chong Zhu;Daniel A. Weiser;Sana Mohiuddin

    (2020)
    13 Citations
  • Clinical Outcomes of Osteoarticular Extracorporeal Irradiated Autograft for Malignant Bone Tumor.

    Satoshi Takenaka;Nobuhito Araki;Takafumi Ueda;Shigeki Kakunaga

    (2020)
    11 Citations
  • Patterns of Perioperative Treatment and Survival of Localized, Resected, Intermediate- or High-Grade Soft Tissue Sarcoma: A 2000-2017 Netherlands Cancer Registry Database Analysis.

    Milan Van Meekeren;Marta Fiocco;Vincent K Y Ho;Judith V M G Bovée

    (2021)
    10 Citations

Related Online Degrees & Career Pathways

For those interested in the medical field but seeking alternatives to traditional medical degrees, there are several online programs and certifications that provide valuable career opportunities. For example, pursuing an online phd nursing can be a great option for advancing clinical expertise and leadership within healthcare without attending on-campus programs.

Another growing area is medical billing and coding, where students can enroll in online medical billing and coding schools that accept fafsa. These programs provide a flexible path to entry-level healthcare administration roles, especially appealing for those seeking financial aid options.

Graduates with a biology degree often explore diverse careers beyond medicine. High-paying jobs with biology degree include research, pharmaceuticals, and biotechnology, offering ample room for growth and specialization.

For professionals wanting to specialize further, certifications like the certified coding specialist credential can enhance job prospects and salary potential in medical coding, a vital role ensuring accuracy in healthcare documentation and billing.

Best Scientists Contributing to This Journal

Recently Published Articles